Eli Lilly’s obesity drug beats rival in head-to-head trial — where Cramer sees shares going next

Health, Fitness & Food

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. 
Scott Olson | Getty Images

New trial data has cemented Club holding Eli Lilly‘s pole position in the highly competitive obesity drug race.

Products You May Like

Articles You May Like

Running Is Inherently Political — and It’s About Time TikTok Has the Conversation
Why nursing homes and hospice are so expensive in the U.S.
Hims & Hers shares plunge 28% on concerns over weight loss business, margins
French Onion Chicken Soup
Fitfluencers Can’t Get Enough of Hot Yoga. Are the Benefits Legit Though?

Leave a Reply

Your email address will not be published. Required fields are marked *